🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The NEOPECS trial is a phase II prospective, single-arm, non-randomised int...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-30
Trial ID
NCT06418724
Treatments Being Tested
The aim of this study is to investigate the safety and the clinical activit...
Status
Active Not Recruiting
Location
CHRU BESANCON - Hopital Jean Minjoz
Start Date
2020-12-14
Trial ID
NCT04652076
Treatments Being Tested
The goal of this clinical trial is to evaluate if adding chemotherapy and i...
Status
Not Yet Recruiting
Location
Fudan Universtiy Shanghai Cancer Center
Start Date
2026-09-01
Trial ID
NCT07776340
The purpose of this study is to evaluate the safety and clinical activity o...
Status
Recruiting
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2026-07-14
Trial ID
NCT07281768
Treatments Being Tested
This is a global, multi-center, Phase 3 study that is randomized 1:1, contr...
Status
Active Not Recruiting
Location
Mayo Clinic Arizona
Start Date
2025-05-30
Trial ID
NCT06790966
Treatments Being Tested
This study is a Phase II, multi-site, randomized, open-label clinical study...
Status
Active Not Recruiting
Location
Beverly Hills Cancer Center
Start Date
2024-08-26
Trial ID
NCT06449222
This is a study using pembrolizumab (MK-3475, KEYTRUDA®) for first-line tre...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-24
Trial ID
NCT02335424
Treatments Being Tested
In order to determine the speed of onset of the anaesthetic propofol in chi...
Status
Completed
Location
Universitäts Kinderspital beider Basel
Start Date
2018-04-23
Trial ID
NCT03426462
Treatments Being Tested
This is a single institution, open-label, multi-arm, pilot study assessing ...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2018-10-31
Trial ID
NCT03422094
Treatments Being Tested
In this phase II study, participants will receive the VRP-HER2 immunization...
Status
Terminated
Location
Duke University
Start Date
2019-03-01
Trial ID
NCT03632941
Treatments Being Tested